Inventor
EL AHMAD YOUSSEF
FR32 patents
⚠️ This page may combine multiple inventors who share the name “EL AHMAD YOUSSEF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVENTIS PHARMA SA
14 patentsUS6403610B1Jun 11, 2002
Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
AVENTIS PHARMA SA71 citations96
US6602884B2Aug 5, 2003
Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
AVENTIS PHARMA SA53 citations95
US6903217B2Jun 7, 2005
Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
AVENTIS PHARMA SA37 citations92
US6603005B2Aug 5, 2003
Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
AVENTIS PHARMA SA45 citations92
US7354933B2Apr 8, 2008
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
AVENTIS PHARMA SA27 citations90
US7528147B2May 5, 2009
Pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
AVENTIS PHARMA SA8 citations82
US7935819B2May 3, 2011
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
AVENTIS PHARMA SA15 citations81
US7560571B2Jul 14, 2009
Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof
AVENTIS PHARMA SA5 citations62
US7524838B2Apr 28, 2009
Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
AVENTIS PHARMA SA4 citations60
US7968566B2Jun 28, 2011
Pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
AVENTIS PHARMA SA0 citations51
US8048893B2Nov 1, 2011
Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
AVENTIS PHARMA SA1 citations50
US7825115B2Nov 2, 2010
Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors
AVENTIS PHARMA SA1 citations50
US7759379B2Jul 20, 2010
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
AVENTIS PHARMA SA1 citations50
US7786114B2Aug 31, 2010
Bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
AVENTIS PHARMA SA0 citations36
SANOFI SA
8 patentsUS9714221B1Jul 25, 2017
Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof
SANOFI SA18 citations91
US11214541B2Jan 4, 2022
Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof
SANOFI SA7 citations84
US10570090B2Feb 25, 2020
Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof
SANOFI SA10 citations83
US11149031B2Oct 19, 2021
Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof
SANOFI SA6 citations72
US11739100B2Aug 29, 2023
2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof
SANOFI SA0 citations60
US9321790B2Apr 26, 2016
Pyrimidinone derivatives as antimalarial agents
SANOFI SA2 citations56
US10253043B2Apr 9, 2019
2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof
SANOFI SA0 citations50
US12545640B2Feb 10, 2026
Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof
SANOFI SA0 citations48
SANOFI AVENTIS
2 patentsBROLLO MAURICE
2 patentsUS9133168B2Sep 15, 2015
Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
BROLLO MAURICE5 citations68
US8828997B2Sep 9, 2014
2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
BROLLO MAURICE0 citations36